Inhibikase Therapeutics, Inc. Common Stock

$1.55

Change

+0.03(+1.64%)

Volume

606.855K($940.61K)

Market Capitalization

$187.96M

Inhibikase Therapeutics Price Charts

Inhibikase Therapeutics Price Chart11:5 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM1.551.551.541.531.521.521.51

Inhibikase Therapeutics Market Segments

After Hours

*No Trades in Segment

Regular Trading Hours

+0.00(+0.00%)
Open$1.55
Close$1.55
Low$1.50
Low Change-0.05 (-3.23%)
High$1.56
High Change+0.01 (+0.65%)
Range$0.06
Volume606.354K
Dollar Volume$939.85K

Premarket

+0.00(+0.00%)
Open$1.52
Close$1.52
Low$1.52
Low Change0.00 (0.00%)
High$1.52
High Change+0.00 (+0.00%)
Range$0.00
Volume501
Dollar Volume$761.52

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

+0.01(+0.33%)
Open$1.52
Close$1.53
Low$1.48
Low Change-0.04 (-2.63%)
High$1.57
High Change+0.05 (+3.22%)
Range$0.09
Volume447.011K
Dollar Volume$681.69K

Premarket Yesterday

*No Trades in Segment

Inhibikase Therapeutics Stock Splits

There has been 1 stock split for Inhibikase Therapeutics (IKT). The reverse stock split occured on June 30, 2023 and reduced the outstanding shares at a ratio of 6:1.

DateTypeRatio
June 30, 2023Reverse6:1